Ever since the G8 summit on Dementia less than a year ago there has been a huge upsurge in international research activity in the field. In the UK, our friends at MRC Technology (an independent medical research charity which aims to bridge the gap between fundamental research and clinical application) were instrumental in forming a Dementia Consortium to aid drug discovery and help charities, universities and drug companies to work more closely together.
Earlier this year, the MND Association and ALS Association met with MRCT to discuss the possibility of extending the collaborative model across other neurodegenerative diseases such as MND and Parkinson’s disease. This idea has generated a lot of enthusiasm from charities and patient organisations on both sides of the Atlantic, which has resulted in the launch of the Neurodegeneration Medicines Acceleration Program at the Partnering for Cures conference in New York. Read the rest of this entry »